Human medicines European public assessment report (EPAR): Rozlytrek, entrectinib, Date of authorisation: 31/07/2020, Revision: 11, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 10 June 2025 - 15:50

Human medicines European public assessment report (EPAR): Rozlytrek, entrectinib, Date of authorisation: 31/07/2020, Revision: 11, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/rozlytrek

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters